Organisation paid for research Program year 2025 Source: CMS Open Payments

Harlem Cardiology

Neither a doctor nor a teaching hospital

Research payments

$167,428

201 payments

Through program year 2025, Harlem Cardiology is reported as receiving $167,428 in research payments, across 201 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $442 2
2022 Research $2,125 1
2021 Research $22,978 36
2020 Research $36,457 47
2019 Research $105,426 115

Breakdown

Who paid Research payments · program years 2019–2025
  1. Boehringer Ingelheim Pharma GmbH & Co.KG $85,392 25 payments
  2. Boehringer Ingelheim International GmbH $82,036 176 payments
Studies the money was for Research payments · program years 2019–2025
  1. Empagliflozin and heart failure (HFpEF) $147,565 152 payments
  2. Empagliflozin and Heart failure (HFrEF) $17,296 46 payments
  3. Empagliflozin and Heart failure HFrEF $2,125 1 payment
  4. A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease. $442 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record